Blog
Author: Justin Egwudo
Q2 2023, Message From The CEO
Good day from buoyant Boston! Recall from my Q1 message that we went into 2023 with three primary objectives – transition, take stock, and time our next sprint – intending to time our next sprint with a pivot to the United States, specifically Boston. Well, here we are. I am slowly settling into the hustle…
Q1 2023, Message From The CEO
Transition, taking stock, timing our next run. These have been the themes of the company in Q1 2023. An element of venture company building that has always bothered me and felt misaligned with our founding mission and raison d’etat is the overemphasis on speed. Those in entrepreneurial circles will be familiar with the maxims, “move…
Q4 2022, Message From The CEO
What a year 2022 turned out to be. Our 2nd year in operation had its fair share of challenges and triumphs. And while everything did not go exactly to plan, we ended the year full of excitement for what is to come in 2023. The major highlights of the final quarter of 2022 were: 1.)…
KDE | Chapter One: Cardiovascular Disease
Introduction to Cardiovascular Disease Heart disease accounts for one in every four deaths in the U.S., according to the Centers for Disease Control and Prevention (CDC). Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels. These conditions develop when plaque builds up in the arteries (atherosclerosis), causing a narrowing…
Q2 2022, Message From The CEO
Where did all the time go? It feels like only 1 week ago that I was writing my first ever “Message from the CEO” for the Q1 Investor Report. I guess it is true what they say: “time flies when you are building a digital health and advocacy startup that is committed to preventing kidney…
